Christophe joined Matignon Technologies in 2001 where he has focused on MedTech, his primary area of interest. He has invested in a wide range of Medtech companies, from computer assisted surgery, biodegradable stents, pulmonary stents, glucose monitoring, masks for sleep apnea, nanoparticles for cancer therapy, internet diet tools and in vitro diagnostics.

He has also invested in high technology content software companies: SWT which was acquired by Captiva Software, and Earth Decision Sciences, which merged with Paradigm.

Christophe likes solid, disruptive technologies.
Prior to Matignon, he was a strategy consultant at the Boston Consulting Group in Paris where he specialized in technology. Christophe is a graduate of the French engineering school Ecole des Mines de Paris, holds a Master of Science degree and an MBA He began his career at the University of Minnesota where he wrote a thesis and also published a scientific paper. He has spent 12 years in North America.